Global Metabolic Syndrome Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

September 2018 | 139 pages | ID: G4C4BE90B6FEN
GlobalInfoResearch

Abstracts

Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes.

Scope of the Report:

This report studies the Metabolic Syndrome market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Metabolic Syndrome market by product type and applications/end industries.

One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.

The global Metabolic Syndrome market is valued at 24600 million USD in 2017 and is expected to reach 33400 million USD by the end of 2023, growing at a CAGR of 5.2% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Metabolic Syndrome.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

• Novo Nordisk
• Sanofi
• Merck
• AstraZeneca
• Eli Lily
• AbbVie
• Actelion Pharmaceuticals
• Adocia
• Aegerion Pharmaceuticals
• Akros Pharma
• Alnylam Pharmaceuticals
• Amarin
• nAmgen
• Amicus Therapeutics
• Arbutus Biopharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers

• Diabetes
• Obesity
• Hypercholesterolemia
• Lysosomal storage diseases

Market Segment by Applications, can be divided into

• Hospital
• Clinic
• Others
  
  

Contents

1 METABOLIC SYNDROME MARKET OVERVIEW

1.1 Product Overview and Scope of Metabolic Syndrome
1.2 Classification of Metabolic Syndrome by Types
  1.2.1 Global Metabolic Syndrome Revenue Comparison by Types (2017-2023)
  1.2.2 Global Metabolic Syndrome Revenue Market Share by Types in 2017
  1.2.3 Diabetes
  1.2.4 Obesity
  1.2.5 Hypercholesterolemia
  1.2.6 Lysosomal storage diseases
1.3 Global Metabolic Syndrome Market by Application
  1.3.1 Global Metabolic Syndrome Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Global Metabolic Syndrome Market by Regions
  1.4.1 Global Metabolic Syndrome Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Metabolic Syndrome Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Metabolic Syndrome Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metabolic Syndrome Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Metabolic Syndrome Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metabolic Syndrome Status and Prospect (2013-2023)
1.5 Global Market Size of Metabolic Syndrome (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Novo Nordisk
  2.1.1 Business Overview
  2.1.2 Metabolic Syndrome Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Novo Nordisk Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi
  2.2.1 Business Overview
  2.2.2 Metabolic Syndrome Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Sanofi Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
  2.3.1 Business Overview
  2.3.2 Metabolic Syndrome Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Merck Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.4 AstraZeneca
  2.4.1 Business Overview
  2.4.2 Metabolic Syndrome Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 AstraZeneca Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.5 Eli Lily
  2.5.1 Business Overview
  2.5.2 Metabolic Syndrome Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Eli Lily Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.6 AbbVie
  2.6.1 Business Overview
  2.6.2 Metabolic Syndrome Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 AbbVie Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.7 Actelion Pharmaceuticals
  2.7.1 Business Overview
  2.7.2 Metabolic Syndrome Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Actelion Pharmaceuticals Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.8 Adocia
  2.8.1 Business Overview
  2.8.2 Metabolic Syndrome Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Adocia Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aegerion Pharmaceuticals
  2.9.1 Business Overview
  2.9.2 Metabolic Syndrome Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Aegerion Pharmaceuticals Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.10 Akros Pharma
  2.10.1 Business Overview
  2.10.2 Metabolic Syndrome Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Akros Pharma Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.11 Alnylam Pharmaceuticals
  2.11.1 Business Overview
  2.11.2 Metabolic Syndrome Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Alnylam Pharmaceuticals Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.12 Amarin
  2.12.1 Business Overview
  2.12.2 Metabolic Syndrome Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 Amarin Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.13 nAmgen
  2.13.1 Business Overview
  2.13.2 Metabolic Syndrome Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 nAmgen Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.14 Amicus Therapeutics
  2.14.1 Business Overview
  2.14.2 Metabolic Syndrome Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 Amicus Therapeutics Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.15 Arbutus Biopharma
  2.15.1 Business Overview
  2.15.2 Metabolic Syndrome Type and Applications
    2.15.2.1 Product A
    2.15.2.2 Product B
  2.15.3 Arbutus Biopharma Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL METABOLIC SYNDROME MARKET COMPETITION, BY PLAYERS

3.1 Global Metabolic Syndrome Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Metabolic Syndrome Players Market Share
  3.2.2 Top 10 Metabolic Syndrome Players Market Share
3.3 Market Competition Trend

4 GLOBAL METABOLIC SYNDROME MARKET SIZE BY REGIONS

4.1 Global Metabolic Syndrome Revenue and Market Share by Regions
4.2 North America Metabolic Syndrome Revenue and Growth Rate (2013-2018)
4.3 Europe Metabolic Syndrome Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Metabolic Syndrome Revenue and Growth Rate (2013-2018)
4.5 South America Metabolic Syndrome Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Metabolic Syndrome Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA METABOLIC SYNDROME REVENUE BY COUNTRIES

5.1 North America Metabolic Syndrome Revenue by Countries (2013-2018)
5.2 USA Metabolic Syndrome Revenue and Growth Rate (2013-2018)
5.3 Canada Metabolic Syndrome Revenue and Growth Rate (2013-2018)
5.4 Mexico Metabolic Syndrome Revenue and Growth Rate (2013-2018)

6 EUROPE METABOLIC SYNDROME REVENUE BY COUNTRIES

6.1 Europe Metabolic Syndrome Revenue by Countries (2013-2018)
6.2 Germany Metabolic Syndrome Revenue and Growth Rate (2013-2018)
6.3 UK Metabolic Syndrome Revenue and Growth Rate (2013-2018)
6.4 France Metabolic Syndrome Revenue and Growth Rate (2013-2018)
6.5 Russia Metabolic Syndrome Revenue and Growth Rate (2013-2018)
6.6 Italy Metabolic Syndrome Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC METABOLIC SYNDROME REVENUE BY COUNTRIES

7.1 Asia-Pacific Metabolic Syndrome Revenue by Countries (2013-2018)
7.2 China Metabolic Syndrome Revenue and Growth Rate (2013-2018)
7.3 Japan Metabolic Syndrome Revenue and Growth Rate (2013-2018)
7.4 Korea Metabolic Syndrome Revenue and Growth Rate (2013-2018)
7.5 India Metabolic Syndrome Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Metabolic Syndrome Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA METABOLIC SYNDROME REVENUE BY COUNTRIES

8.1 South America Metabolic Syndrome Revenue by Countries (2013-2018)
8.2 Brazil Metabolic Syndrome Revenue and Growth Rate (2013-2018)
8.3 Argentina Metabolic Syndrome Revenue and Growth Rate (2013-2018)
8.4 Colombia Metabolic Syndrome Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE METABOLIC SYNDROME BY COUNTRIES

9.1 Middle East and Africa Metabolic Syndrome Revenue by Countries (2013-2018)
9.2 Saudi Arabia Metabolic Syndrome Revenue and Growth Rate (2013-2018)
9.3 UAE Metabolic Syndrome Revenue and Growth Rate (2013-2018)
9.4 Egypt Metabolic Syndrome Revenue and Growth Rate (2013-2018)
9.5 Nigeria Metabolic Syndrome Revenue and Growth Rate (2013-2018)
9.6 South Africa Metabolic Syndrome Revenue and Growth Rate (2013-2018)

10 GLOBAL METABOLIC SYNDROME MARKET SEGMENT BY TYPE

10.1 Global Metabolic Syndrome Revenue and Market Share by Type (2013-2018)
10.2 Global Metabolic Syndrome Market Forecast by Type (2018-2023)
10.3 Diabetes Revenue Growth Rate (2013-2023)
10.4 Obesity Revenue Growth Rate (2013-2023)
10.5 Hypercholesterolemia Revenue Growth Rate (2013-2023)
10.6 Lysosomal storage diseases Revenue Growth Rate (2013-2023)

11 GLOBAL METABOLIC SYNDROME MARKET SEGMENT BY APPLICATION

11.1 Global Metabolic Syndrome Revenue Market Share by Application (2013-2018)
11.2 Metabolic Syndrome Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Clinic Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)

12 GLOBAL METABOLIC SYNDROME MARKET SIZE FORECAST (2018-2023)

12.1 Global Metabolic Syndrome Market Size Forecast (2018-2023)
12.2 Global Metabolic Syndrome Market Forecast by Regions (2018-2023)
12.3 North America Metabolic Syndrome Revenue Market Forecast (2018-2023)
12.4 Europe Metabolic Syndrome Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Metabolic Syndrome Revenue Market Forecast (2018-2023)
12.6 South America Metabolic Syndrome Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Metabolic Syndrome Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Metabolic Syndrome Picture
Table Product Specifications of Metabolic Syndrome
Table Global Metabolic Syndrome and Revenue (Million USD) Market Split by Product Type
Figure Global Metabolic